GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Stoke Therapeutics, Inc. - Common Stock, par value $0.0001 per share (STOK)

Symbol: STOK on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$37,019,868	1,166,145	+19,145	+1.7%	$31.75	Q4 2025
30 Sep 2025	0%	+0%	$26,959,632	1,147,000	+174,079	+18%	$23.50	Q3 2025
30 Jun 2025	0%	+0%	$11,044,249	972,921	+70,935	+7.9%	$11.35	Q2 2025
31 Mar 2025	0%	+0%	$5,999,613	901,986	+24,891		$6.65	Q1 2025
31 Dec 2024	0%	+0%	$9,676,682	877,095	+6,264	+0.72%	$11.03	Q4 2024
30 Sep 2024	0%	+0%	$10,704,600	870,831	+76,661	+9.7%	$12.29	Q3 2024
30 Jun 2024	0%	+0%	$10,731,632	794,170	+154,363	+24%	$13.51	Q2 2024
31 Mar 2024	0%	+0%	$8,638,351	639,807	+24,083	+3.9%	$13.50	Q1 2024
31 Dec 2023	0%	+0%	$3,239,050	615,724	+24,607	+4.2%	$5.26	Q4 2023
30 Sep 2023	0%	-0%	$2,329,283	591,117	-8,663	-1.4%	$3.94	Q3 2023
30 Jun 2023	0%	+0%	$6,375,661	599,780	+113,100	+23%	$10.63	Q2 2023
31 Mar 2023	0%	+0%	$4,054,044	486,680	+12,456	+2.6%	$8.33	Q1 2023
31 Dec 2022	0%	+0%	$4,377,000	474,224	+13,969	+3%	$9.23	Q4 2022
30 Sep 2022	0%	+0%	$5,909,000	460,255	+16,446	+3.7%	$12.84	Q3 2022
30 Jun 2022	0%	+0%	$5,862,000	443,809	+8,038	+1.8%	$13.21	Q2 2022
31 Mar 2022	0%	+0%	$9,172,000	435,771	+59,617	+16%	$21.05	Q1 2022
31 Dec 2021	0%	+0%	$9,023,000	376,154	+12,819	+3.5%	$23.99	Q4 2021
30 Sep 2021	0%	+0%	$9,243,000	363,335	+7,089	+2%	$25.44	Q3 2021
30 Jun 2021	0%	+0%	$11,991,000	356,246	+63,210	+22%	$33.66	Q2 2021
31 Mar 2021	0%	+0%	$11,381,000	293,036	+21,871	+8.1%	$38.84	Q1 2021
31 Dec 2020	0%	+0%	$16,793,000	271,165	+68,976	+34%	$61.93	Q4 2020
30 Sep 2020	0%	+0%	$6,771,000	202,189	+42,245	+26%	$33.49	Q3 2020
30 Jun 2020	0%	-0%	$3,811,000	159,944	-25,912	-14%	$23.83	Q2 2020
31 Mar 2020	0%	+0%	$4,256,000	185,856	+66,139	+55%	$22.90	Q1 2020
31 Dec 2019	0%	+0%	$3,390,000	119,717	+6,965	+6.2%	$28.32	Q4 2019
30 Sep 2019	0%	+0%	$2,423,000	112,752	+112,752	NEW	$21.49	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.